Cargando…

Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer

BACKGROUND: Cetuximab has been regularly added to the treatments for metastatic colorectal cancer worldwide. However, due to its therapeutic insensitivity and underlying mechanisms being largely unknown, the clinical implementation of cetuximab in colorectal cancer remains limited. METHODS: The gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Chaoran, Hong, Hiju, Lu, Jiaoyang, Zhao, Xuan, Hu, Wenjun, Zhang, Sen, Zong, Yaping, Mao, Zhihai, Li, Jianwen, Wang, Mingliang, Feng, Bo, Sun, Jing, Zheng, Minhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196627/ https://www.ncbi.nlm.nih.gov/pubmed/30336768 http://dx.doi.org/10.1177/1533033818806905

Ejemplares similares

Identification of key genes and pathways involved in microsatellite instability in colorectal cancer
por: Yu, Chaoran, et al.
Publicado: (2019)

NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer
por: Yang, Guang, et al.
Publicado: (2021)

Identification of Key Genes and Pathways Involved in Circulating Tumor Cells in Colorectal Cancer
por: Pan, Ruijun, et al.
Publicado: (2022)

Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology
por: Yang, Xiao, et al.
Publicado: (2020)

N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21
por: Zhang, Sen, et al.
Publicado: (2019)

Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
por: Wang, Chenxing, et al.
Publicado: (2022)

Characterization of the prognostic values of the NDRG family in gastric cancer
por: Yu, Chaoran, et al.
Publicado: (2019)

N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2
por: Yang, Xiao, et al.
Publicado: (2017)

Prefoldin subunits (PFDN1–6) serve as poor prognostic markers in gastric cancer
por: Yesseyeva, Galiya, et al.
Publicado: (2020)

An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients
por: Shao, Yanfei, et al.
Publicado: (2021)

E2A suppresses invasion and migration by targeting YAP in colorectal cancer cells
por: Zhao, Hongchao, et al.
Publicado: (2013)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

The Metastasis Suppressor, N-myc Downregulated Gene 1 (NDRG1), Is a Prognostic Biomarker for Human Colorectal Cancer
por: Mao, Zhihai, et al.
Publicado: (2013)

Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature
por: Zhou, Xueliang, et al.
Publicado: (2022)

Prognostic value of the mRNA expression of gap junction α members in patients with gastric cancer
por: Zhao, Xuan, et al.
Publicado: (2019)

NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity
por: Aikemu, Batuer, et al.
Publicado: (2021)

ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer: ACACB is a biomarker for CTX therapy in metastatic CRC
por: Hong, Hi-Ju, et al.
Publicado: (2022)

Evolving role of cetuximab in the treatment of colorectal cancer
por: Schuch, Gunter, et al.
Publicado: (2009)

PRSS contributes to cetuximab resistance in colorectal cancer
por: Tan, Zhaoli, et al.
Publicado: (2020)

Resveratrol Sensitizes Colorectal Cancer Cells to Cetuximab by Connexin 43 Upregulation-Induced Akt Inhibition
por: Wang, Yijia, et al.
Publicado: (2020)

GJA1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Colorectal Cancer
por: Hu, Wenjun, et al.
Publicado: (2020)

Identification of hub genes associated with neutrophils infiltration in colorectal cancer
por: Su, Hao, et al.
Publicado: (2021)

CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer
por: Ou, Baochi, et al.
Publicado: (2016)

Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer
por: Park, Seong Hye, et al.
Publicado: (2019)

Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways
por: Zhao, Jingkun, et al.
Publicado: (2017)

A cognitive pathway to punishment insensitivity
por: Jean-Richard-dit-Bressel, Philip, et al.
Publicado: (2023)

Exploring the relationship between lactate metabolism and immunological function in colorectal cancer through genes identification and analysis
por: Zhang, Enkui, et al.
Publicado: (2023)

A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells
por: Landi, Nicola, et al.
Publicado: (2023)

Correction: CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer
por: Ou, Baochi, et al.
Publicado: (2017)

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
por: Dunn, Emily F., et al.
Publicado: (2010)

PTEN status in advanced colorectal cancer treated with cetuximab
por: Negri, F V, et al.
Publicado: (2010)

Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance
por: Tak, Eunyoung, et al.
Publicado: (2022)

First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
por: Tonini, Giuseppe, et al.
Publicado: (2009)

N-myc downstream-regulated gene 1 promotes apoptosis in colorectal cancer via up-regulating death receptor 4
por: Zhang, Xian, et al.
Publicado: (2017)

Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells
por: Huang, Suning, et al.
Publicado: (2014)

Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer
por: Yang, Ying-nan, et al.
Publicado: (2018)

MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer
por: Zhang, Wenpeng, et al.
Publicado: (2014)

Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis
por: Neyns, B., et al.
Publicado: (2008)

Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer
por: Dahan, Laetitia, et al.
Publicado: (2011)

Right- and left-sided colorectal cancers respond differently to cetuximab
por: Wang, Feng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j528oqekf94pfetr567rjd8df1